AU3423578A – Liposomes
– Google Patents
AU3423578A – Liposomes
– Google Patents
Liposomes
Info
Publication number
AU3423578A
AU3423578A
AU34235/78A
AU3423578A
AU3423578A
AU 3423578 A
AU3423578 A
AU 3423578A
AU 34235/78 A
AU34235/78 A
AU 34235/78A
AU 3423578 A
AU3423578 A
AU 3423578A
AU 3423578 A
AU3423578 A
AU 3423578A
Authority
AU
Australia
Prior art keywords
liposomes
Prior art date
1977-05-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU34235/78A
Other versions
AU514644B2
(en
Inventor
JR. Fildes F. J. T. and Oliver J. E Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1977-05-10
Filing date
1978-03-17
Publication date
1979-09-20
1978-03-17
Application filed by Imperial Chemical Industries Ltd
filed
Critical
Imperial Chemical Industries Ltd
1979-09-20
Publication of AU3423578A
publication
Critical
patent/AU3423578A/en
1981-02-19
Application granted
granted
Critical
1981-02-19
Publication of AU514644B2
publication
Critical
patent/AU514644B2/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/10—Dispersions; Emulsions
A61K9/127—Liposomes
A61K9/1277—Processes for preparing; Proliposomes
AU34235/78A
1977-05-10
1978-03-17
Liposomes
Expired
AU514644B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GBGB19510/77
1977-05-10
GB19510/77A
GB1575343A
(en)
1977-05-10
1977-05-10
Method for preparing liposome compositions containing biologically active compounds
Publications (2)
Publication Number
Publication Date
AU3423578A
true
AU3423578A
(en)
1979-09-20
AU514644B2
AU514644B2
(en)
1981-02-19
Family
ID=10130587
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU34235/78A
Expired
AU514644B2
(en)
1977-05-10
1978-03-17
Liposomes
Country Status (19)
Country
Link
US
(2)
US4311712A
(en)
JP
(1)
JPS53142514A
(en)
AU
(1)
AU514644B2
(en)
BE
(1)
BE866697A
(en)
CA
(1)
CA1114758A
(en)
CH
(2)
CH650944A5
(en)
DE
(1)
DE2818655A1
(en)
DK
(2)
DK156765C
(en)
FI
(1)
FI63856C
(en)
FR
(1)
FR2390159A1
(en)
GB
(1)
GB1575343A
(en)
IE
(1)
IE46571B1
(en)
IL
(2)
IL54270A
(en)
IT
(1)
IT1094811B
(en)
NL
(1)
NL7805005A
(en)
NO
(3)
NO150184C
(en)
NZ
(1)
NZ186696A
(en)
SE
(3)
SE440725B
(en)
ZA
(1)
ZA781416B
(en)
Families Citing this family (122)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
CH621479A5
(en)
*
1977-08-05
1981-02-13
Battelle Memorial Institute
IT1110989B
(en)
*
1979-01-19
1986-01-13
Erba Farmitalia
PHARMACEUTICAL FORMS CONSTITUTED BY LIPOSOMES AND RELATED PROCEDURES
FR2416008A1
(en)
*
1978-02-02
1979-08-31
Oreal
LIPOSOME LYOPHILISATES
IT1111367B
(en)
*
1978-11-17
1986-01-13
Serono Ist Farm
PROCESS FOR THE ETHERPORARY PREPARATION OF LIPOSOMES AND LIPOSOMES SO OBTAINED
JPS55118415A
(en)
*
1979-02-28
1980-09-11
Pii Papahadojiyopo Dometoriosu
Method of encapsulating biologically active substance in lipoid cell
DE2914789A1
(en)
*
1979-04-11
1980-10-16
Nattermann A & Cie
INJECTABLE MEDICINES WITH ANTI-INFLAMMATORY EFFECT
DE2914788A1
(en)
*
1979-04-11
1980-10-16
Nattermann A & Cie
PARENTERAL APPLICABLE, STABLE DRUG SOLUTIONS WITH ANTI-INFLAMMATORY EFFECT
JPS55153713A
(en)
*
1979-05-02
1980-11-29
Kureha Chem Ind Co Ltd
Pharmaceutical preparation of ribosome containing active substance
CA1173360A
(en)
*
1979-06-22
1984-08-28
Jurg Schrank
Pharmaceutical preparations
US4310505A
(en)
*
1979-11-08
1982-01-12
California Institute Of Technology
Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
HU184141B
(en)
*
1979-12-27
1984-07-30
Human Oltoanyagtermelo
Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
JPS5775916A
(en)
*
1980-10-29
1982-05-12
Nippon Chemiphar Co Ltd
Coenzyme q pharmaceutical and its preparation
JPS57146710A
(en)
*
1981-03-07
1982-09-10
Kunio Yagi
Blood brain-barrier permeating ribosome-like microcapsule
US4397846A
(en)
*
1981-05-15
1983-08-09
Murray Weiner
Storage-stable lipid vesicles and method of preparation
JPS58128318A
(en)
*
1982-01-22
1983-07-30
フアイソンズ・ピ−エルシ−
Pharmaceutical composition
JPS58222014A
(en)
*
1982-06-18
1983-12-23
Taisho Pharmaceut Co Ltd
Prostaglandin e1 oil emulsion
US4588578A
(en)
*
1983-08-08
1986-05-13
The Liposome Company, Inc.
Lipid vesicles prepared in a monophase
GB8322178D0
(en)
*
1983-08-17
1983-09-21
Sterwin Ag
Preparing aerosol compositions
US4744989A
(en)
*
1984-02-08
1988-05-17
E. R. Squibb & Sons, Inc.
Method of preparing liposomes and products produced thereby
US5141674A
(en)
*
1984-03-08
1992-08-25
Phares Pharmaceutical Research N.V.
Methods of preparing pro-liposome dispersions and aerosols
JPS60208910A
(en)
*
1984-03-31
1985-10-21
Green Cross Corp:The
Preparation of composite of hardly water-soluble drug and phospholipid
SE8403905D0
(en)
*
1984-07-30
1984-07-30
Draco Ab
LIPOSOMES AND STEROID ESTERS
US5736155A
(en)
*
1984-08-08
1998-04-07
The Liposome Company, Inc.
Encapsulation of antineoplastic agents in liposomes
US5077056A
(en)
*
1984-08-08
1991-12-31
The Liposome Company, Inc.
Encapsulation of antineoplastic agents in liposomes
US4880635B1
(en)
*
1984-08-08
1996-07-02
Liposome Company
Dehydrated liposomes
DE3582905D1
(en)
*
1984-08-10
1991-06-27
Syntex Inc
STABLE LIPOSOME WITH WATER-SOLUBLE MEDICINAL PRODUCTS.
JPS6150912A
(en)
*
1984-08-16
1986-03-13
Shionogi & Co Ltd
Production of liposome preparation
JPS61100518A
(en)
*
1984-10-22
1986-05-19
Ono Pharmaceut Co Ltd
Lyophilized ribosome pharmaceutical preparation comprising dimyristoylphosphatidylcholine as main component
US4857319A
(en)
*
1985-01-11
1989-08-15
The Regents Of The University Of California
Method for preserving liposomes
US4830858A
(en)
*
1985-02-11
1989-05-16
E. R. Squibb & Sons, Inc.
Spray-drying method for preparing liposomes and products produced thereby
US5409704A
(en)
*
1985-06-26
1995-04-25
The Liposome Company, Inc.
Liposomes comprising aminoglycoside phosphates and methods of production and use
FR2591105B1
(en)
*
1985-12-11
1989-03-24
Moet Hennessy Rech
PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, OR COSMETIC, BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING A RETINOIDE OR A STRUCTURAL ANALOG OF SUCH A RETINOID AS A CAROTENOID.
US5068198A
(en)
*
1986-03-26
1991-11-26
Syntex (U.S.A.) Inc.
Liquid single reagent for assays involving confining gels
SE8601457D0
(en)
*
1986-04-01
1986-04-01
Draco Ab
COMPOSITIONS OF LIPOSOMES AND B? 712 RECEPTOR ACTIVE SUBSTANCES FOR INHALATION
FR2597345B1
(en)
*
1986-04-22
1990-08-03
Oreal
COSMETIC OR PHARMACEUTICAL COMPOSITION BASED ON AN AQUEOUS DISPERSION OF LIPID SPHERULES.
SE8603812D0
(en)
*
1986-09-12
1986-09-12
Draco Ab
ADMINISTRATION OF LIPOSOMES TO MAMMALS
US4891324A
(en)
*
1987-01-07
1990-01-02
Syntex (U.S.A.) Inc.
Particle with luminescer for assays
US5089181A
(en)
*
1987-02-24
1992-02-18
Vestar, Inc.
Method of dehydrating vesicle preparations for long term storage
US5811119A
(en)
*
1987-05-19
1998-09-22
Board Of Regents, The University Of Texas
Formulation and use of carotenoids in treatment of cancer
US5262168A
(en)
*
1987-05-22
1993-11-16
The Liposome Company, Inc.
Prostaglandin-lipid formulations
WO1988009170A1
(en)
*
1987-05-22
1988-12-01
The Liposome Company, Inc.
Prostaglandin-lipid formulations
US5925375A
(en)
*
1987-05-22
1999-07-20
The Liposome Company, Inc.
Therapeutic use of multilamellar liposomal prostaglandin formulations
US4963362A
(en)
*
1987-08-07
1990-10-16
Regents Of The University Of Minnesota
Freeze-dried liposome mixture containing cyclosporin
US4950432A
(en)
*
1987-10-16
1990-08-21
Board Of Regents, The University Of Texas System
Polyene microlide pre-liposomal powders
US5178875A
(en)
*
1991-01-14
1993-01-12
The Board Of Regents, The University Of Texas System
Liposomal-polyene preliposomal powder and method for its preparation
US5830498A
(en)
*
1987-10-16
1998-11-03
Board Of Regents, The University Of Texas System
Liposomal-polyene preliposomal powder and method for its preparation
US4981690A
(en)
*
1987-10-27
1991-01-01
Board Of Regents, The University Of Texas System
Liposome-incorporated mepartricin
JPH0610131B2
(en)
*
1987-10-30
1994-02-09
テルモ株式会社
Liposomal manufacturing method
EP0397774A1
(en)
*
1988-02-04
1990-11-22
Board Of Regents, The University Of Texas System
Formulation and use of retinoids in treatment of cancer and other diseases
US5096629A
(en)
*
1988-08-29
1992-03-17
501 Nippon Fine Chemical Co., Ltd.
Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
AU4525589A
(en)
*
1988-10-27
1990-05-14
Regents Of The University Of Minnesota
Liposome immunoadjuvants containing il-2
US5174988A
(en)
*
1989-07-27
1992-12-29
Scientific Development & Research, Inc.
Phospholipid delivery system
USRE39146E1
(en)
1990-04-02
2006-06-27
Bracco International B.V.
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US6613306B1
(en)
1990-04-02
2003-09-02
Bracco International B.V.
Ultrasound contrast agents and methods of making and using them
US6989141B2
(en)
*
1990-05-18
2006-01-24
Bracco International B.V.
Ultrasound contrast agents and methods of making and using them
US20040208826A1
(en)
*
1990-04-02
2004-10-21
Bracco International B.V.
Ultrasound contrast agents and methods of making and using them
US5578292A
(en)
1991-11-20
1996-11-26
Bracco International B.V.
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US7083778B2
(en)
*
1991-05-03
2006-08-01
Bracco International B.V.
Ultrasound contrast agents and methods of making and using them
US20010024638A1
(en)
*
1992-11-02
2001-09-27
Michel Schneider
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
IN172208B
(en)
*
1990-04-02
1993-05-01
Sint Sa
US5445813A
(en)
*
1992-11-02
1995-08-29
Bracco International B.V.
Stable microbubble suspensions as enhancement agents for ultrasound echography
AU636481B2
(en)
*
1990-05-18
1993-04-29
Bracco International B.V.
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US20030194376A1
(en)
*
1990-05-18
2003-10-16
Bracco International B.V.
Ultrasound contrast agents and methods of making and using them
EP0555229B1
(en)
*
1990-07-31
1996-06-05
The Liposome Company, Inc.
Accumulation of amino acids and peptides into liposomes
US6251581B1
(en)
1991-05-22
2001-06-26
Dade Behring Marburg Gmbh
Assay method utilizing induced luminescence
US5340716A
(en)
*
1991-06-20
1994-08-23
Snytex (U.S.A.) Inc.
Assay method utilizing photoactivated chemiluminescent label
US5885260A
(en)
*
1991-05-30
1999-03-23
Mehl, Sr.; Thomas L.
Freeze-dried liposome delivery system for application of skin treatment agents
CA2110490C
(en)
*
1991-06-18
2008-07-29
Evan C. Unger
Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior
FR2681781A1
(en)
*
1991-09-30
1993-04-02
Oreal
ANHYDROUS COSMETIC COMPOSITION COMPRISING A FATTY PHASE AND COSMETIC TREATMENT METHOD USING THE SAME.
WO1993012813A1
(en)
*
1991-12-31
1993-07-08
Zymogenetics, Inc.
Methods and compositions for reducing blood loss
IL104084A
(en)
*
1992-01-24
1996-09-12
Bracco Int Bv
Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5736141A
(en)
*
1992-06-05
1998-04-07
Dalhousie University
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund’s adjuvant
USRE37224E1
(en)
*
1992-06-05
2001-06-12
Dalhousie University
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
ATE162892T1
(en)
*
1992-07-31
1998-02-15
Behringwerke Ag
PHOTOACTIVABLE CHEMILUMINIZING MATRICES
DE4309579C3
(en)
*
1993-03-24
2000-01-27
Sanol Arznei Schwarz Gmbh
Pharmaceutical composition in the form of a pack
EP0678017B1
(en)
*
1993-11-05
1998-04-01
Amgen Inc.
Liposome preparation and material encapsulation method
CA2154867C
(en)
*
1993-12-15
2007-05-29
Feng Yan
Gas mixtures useful as ultrasound contrast media
IT1269569B
(en)
*
1994-04-22
1997-04-08
Ugo Citernesi
PROCEDURE FOR THE PREPARATION OF COMPLEX BETWEEN PHOSPHOLIPIDS AND ACTIVE PRINCIPLES USEFUL FOR THE PRODUCTION OF LIPOSOMES AND ACTIVE PRINCIPLES AND LIPOSOMES OBTAINED WITH THE PROCEDURE
US6156337A
(en)
*
1994-07-08
2000-12-05
Opperbas Holding B.V.
Method for high loading of vesicles with biopolymeric substances
IL115099A
(en)
*
1994-10-14
1999-04-11
Upjohn Co
Lyophilizate of phospholipid complex of water insoluble camptothecins
US5990077A
(en)
1995-04-14
1999-11-23
1149336 Ontario Inc.
Glucagon-like peptide-2 and its therapeutic use
US6184201B1
(en)
1995-04-14
2001-02-06
Nps Allelix Corp.
Intestinotrophic glucagon-like peptide-2 analogs
US5834428A
(en)
*
1995-04-14
1998-11-10
1149336 Ontario Inc.
Glucagon-like peptide-2 and its therapeutic use
US5902604A
(en)
*
1995-06-06
1999-05-11
Board Of Regents, The University Of Texas System
Submicron liposome suspensions obtained from preliposome lyophilizates
JP4148994B2
(en)
1996-04-12
2008-09-10
１１４９３３６ オンタリオ インコーポレイテッド
Glucagon-like peptide-2 analog
US6111081A
(en)
*
1996-05-31
2000-08-29
Baylor College Of Medicine
Lactoferrin variants and uses thereof
JP4155601B2
(en)
*
1996-10-25
2008-09-24
モンサント・テクノロジー・エルエルシー
Compositions and methods for treating plants with exogenous chemicals
CZ299552B6
(en)
*
1996-10-25
2008-09-03
Monsanto Technology Llc
Composition and method for treating plants with exogenous chemicals
US6037125A
(en)
*
1996-11-05
2000-03-14
Lexicon Genetics Incorporated
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
CA2236519C
(en)
1997-05-02
2011-09-13
1149336 Ontario Inc.
Methods of enhancing functioning of the large intestine
PL363618A1
(en)
*
2000-11-09
2004-11-29
Neopharm, Inc.
Sn-38 lipid complexes and methods of use
DK1347743T3
(en)
*
2000-12-07
2006-07-03
Univ Utrecht Holding Bv
Preparation for the treatment of inflammatory disorders
WO2003030864A1
(en)
*
2001-05-29
2003-04-17
Neopharm, Inc.
Liposomal formulation of irinotecan
US6939564B2
(en)
*
2001-06-08
2005-09-06
Labopharm, Inc.
Water-soluble stabilized self-assembled polyelectrolytes
US6780324B2
(en)
*
2002-03-18
2004-08-24
Labopharm, Inc.
Preparation of sterile stabilized nanodispersions
US20040082521A1
(en)
*
2002-03-29
2004-04-29
Azaya Therapeutics Inc.
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20060093661A1
(en)
2002-05-07
2006-05-04
Kapac, Llc
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20030212046A1
(en)
*
2002-05-07
2003-11-13
Kapac, Llc
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20050152962A1
(en)
*
2002-06-12
2005-07-14
Metselaar Josbert M.
Composition for treatment of inflammatory disorders
WO2004035032A2
(en)
*
2002-08-20
2004-04-29
Neopharm, Inc.
Pharmaceutical formulations of camptothecine derivatives
US20060030578A1
(en)
*
2002-08-20
2006-02-09
Neopharm, Inc.
Pharmaceutically active lipid based formulation of irinotecan
EP1393720A1
(en)
*
2002-08-27
2004-03-03
Universiteit Utrecht
Vesicle-encapsulated corticosteroids for treatment of cancer
KR100651728B1
(en)
*
2004-11-10
2006-12-06
한국전자통신연구원
Compounds having anchoring group and electronic device including the same and methods for producing the same
US20060198891A1
(en)
2004-11-29
2006-09-07
Francois Ravenelle
Solid formulations of liquid biologically active agents
WO2006071659A1
(en)
*
2004-12-29
2006-07-06
Trustees Of Boston University
Delivery of h2 antagonists
WO2006108637A2
(en)
2005-04-13
2006-10-19
Abbott Gmbh & Co.Kg
Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof
DE102005017777A1
(en)
*
2005-04-13
2006-10-19
Pharmasol Gmbh
Preparation of high fine particle suspension comprises dissolving solid in a solvent, freezing, lyophilizing solid matrix, withdrawing solid matrix from solvent and dispersing in an external phase and applying high power on the dispersion
AU2007298674A1
(en)
*
2006-09-22
2008-03-27
Labopharm (Barbados) Limited
Compositions and methods for pH targeted drug delivery
US7960336B2
(en)
2007-08-03
2011-06-14
Pharmain Corporation
Composition for long-acting peptide analogs
US9168288B2
(en)
2010-04-09
2015-10-27
Mount Sinai Hospital
Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist
WO2012094033A1
(en)
2011-01-05
2012-07-12
Livon Laboratories
Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
WO2015006228A1
(en)
2013-07-08
2015-01-15
The University Of Utah Research Foundation
Methods for treatment of and prophylaxis against inflammatory disorders
US10772926B2
(en)
2016-12-16
2020-09-15
Nutragen Health Innovations, Inc.
Natural drugs for the treatment of inflammation and melanoma
WO2018204918A1
(en)
2017-05-05
2018-11-08
Ardelyx, Inc.
Treatment of hepatic disorders
TW202003020A
(en)
2018-03-21
2020-01-16
美國科羅拉多州立大學研究基金會
Cancer vaccine compositions and methods of use thereof
RU2740553C2
(en)
*
2019-01-30
2021-01-15
Анастасия Андреевна Карбаинова
Method of producing liposomal form of betulin, having hepatoprotective activity
LT6699B
(en)
2019-07-15
2020-02-10
UAB “Valentis”
Method for production of proliposomes by using up to 5% ethanol and the use thereof for encapsulation of lipophilic substances
CA3170563A1
(en)
2020-03-06
2021-09-10
Raymond P. Goodrich
Production of vaccines comprising inactivated sars-cov-2 viral particles
IL300113A
(en)
2020-07-28
2023-03-01
Jazz Pharmaceuticals Ireland Ltd
Fused bicyclic raf inhibitors and methods for use thereof
EP4188923A1
(en)
2020-07-28
2023-06-07
Jazz Pharmaceuticals Ireland Limited
Chiral synthesis of fused bicyclic raf inhibitors
WO2022212863A1
(en)
2021-04-01
2022-10-06
Vestaron Corporation
Liposome formulations for pesticide delivery and methods for producing and using the same
WO2023096858A1
(en)
2021-11-23
2023-06-01
Senda Biosciences, Inc.
A bacteria-derived lipid composition and use thereof
Family Cites Families (13)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3549382A
(en)
*
1968-05-15
1970-12-22
Francis Frederick Hansen
Method of preparing powdered monoglyceride material
FR2081586A2
(en)
*
1970-01-24
1971-12-10
Orsymonde
Dehydrated pharmaceutical comps by – lyophilisation
US3597455A
(en)
*
1969-05-29
1971-08-03
Squibb & Sons Inc
Process for manufacture of sterile lecithin
CH528266A
(en)
*
1969-11-26
1972-09-30
Orsymonde
Process for the preparation of a lyophilized composition for cosmetic or hygienic use
FR2101044A2
(en)
*
1969-11-26
1972-03-31
Orsymonde
Freeze-dried oil – in – water emulsions – for treatment of mouth , teeth, hair and scalp
DE2249552A1
(en)
*
1971-10-12
1973-05-30
Inchema S A
PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS
BE795516A
(en)
*
1972-02-17
1973-08-16
Ciba Geigy
PREPARATIONS OF OILY AND INJECTABLE PEPTIDES AND PROCESS FOR THEIR PREPARATION
CH588887A5
(en)
*
1974-07-19
1977-06-15
Battelle Memorial Institute
US3957971A
(en)
*
1974-07-29
1976-05-18
Lever Brothers Company
Moisturizing units and moisturizing compositions containing the same
JPS5126213A
(en)
*
1974-08-21
1976-03-04
Tanabe Seiyaku Co
JOHOSEIBIRYUSHISEIZAINO SEIHO
JPS5186117A
(en)
*
1975-01-27
1976-07-28
Tanabe Seiyaku Co
Johoseibiryushiseizainoseiho
FR2315991A1
(en)
*
1975-06-30
1977-01-28
Oreal
METHOD OF MANUFACTURING AQUEOUS DISPERSIONS OF LIPID SPHERULES AND CORRESPONDING NEW COMPOSITIONS
DK141082B
(en)
*
1976-01-13
1980-01-14
Battelle Memorial Institute
Process for the preparation of liposomes containing biologically active substance dispersed in an aqueous medium.
1977
1977-05-10
GB
GB19510/77A
patent/GB1575343A/en
not_active
Expired
1978
1978-03-07
IE
IE464/78A
patent/IE46571B1/en
not_active
IP Right Cessation
1978-03-09
NO
NO780838A
patent/NO150184C/en
unknown
1978-03-10
ZA
ZA00781416A
patent/ZA781416B/en
unknown
1978-03-14
NZ
NZ186696A
patent/NZ186696A/en
unknown
1978-03-14
IL
IL54270A
patent/IL54270A/en
unknown
1978-03-17
AU
AU34235/78A
patent/AU514644B2/en
not_active
Expired
1978-04-03
FI
FI781012A
patent/FI63856C/en
not_active
IP Right Cessation
1978-04-07
CA
CA300,720A
patent/CA1114758A/en
not_active
Expired
1978-04-27
DE
DE19782818655
patent/DE2818655A1/en
active
Granted
1978-05-03
BE
BE187387A
patent/BE866697A/en
not_active
IP Right Cessation
1978-05-09
SE
SE7805276A
patent/SE440725B/en
not_active
IP Right Cessation
1978-05-09
JP
JP5487578A
patent/JPS53142514A/en
active
Granted
1978-05-09
CH
CH5038/78A
patent/CH650944A5/en
not_active
IP Right Cessation
1978-05-09
CH
CH6832/82A
patent/CH652615A5/en
not_active
IP Right Cessation
1978-05-09
FR
FR7813632A
patent/FR2390159A1/en
active
Granted
1978-05-10
DK
DK206578A
patent/DK156765C/en
not_active
IP Right Cessation
1978-05-10
IT
IT23207/78A
patent/IT1094811B/en
active
1978-05-10
NL
NL7805005A
patent/NL7805005A/en
active
Search and Examination
1979
1979-08-20
US
US06/067,948
patent/US4311712A/en
not_active
Expired – Lifetime
1980
1980-11-13
IL
IL61475A
patent/IL61475A0/en
unknown
1981
1981-09-18
US
US06/303,578
patent/US4370349A/en
not_active
Expired – Lifetime
1982
1982-03-04
SE
SE8201350A
patent/SE454049B/en
not_active
IP Right Cessation
1982-03-04
SE
SE8201351A
patent/SE453962B/en
not_active
IP Right Cessation
1983
1983-11-17
NO
NO834219A
patent/NO153121C/en
unknown
1984
1984-01-09
NO
NO840064A
patent/NO840064L/en
unknown
1988
1988-03-07
DK
DK122388A
patent/DK122388D0/en
not_active
Application Discontinuation
Also Published As
Publication number
Publication date
IE46571B1
(en)
1983-07-27
SE7805276L
(en)
1978-11-11
SE453962B
(en)
1988-03-21
SE8201351L
(en)
1982-03-04
IE780464L
(en)
1978-11-10
FI63856C
(en)
1983-09-12
DK206578A
(en)
1978-11-11
US4370349A
(en)
1983-01-25
BE866697A
(en)
1978-11-03
IT1094811B
(en)
1985-08-10
NO834219L
(en)
1978-11-13
IL54270A
(en)
1981-06-29
DK122388A
(en)
1988-03-07
ZA781416B
(en)
1979-03-28
FI781012A
(en)
1978-11-11
DK156765B
(en)
1989-10-02
FI63856B
(en)
1983-05-31
DK122388D0
(en)
1988-03-07
SE454049B
(en)
1988-03-28
GB1575343A
(en)
1980-09-17
NO780838L
(en)
1978-11-13
SE440725B
(en)
1985-08-19
IL54270A0
(en)
1978-06-15
DK156765C
(en)
1990-02-19
AU514644B2
(en)
1981-02-19
NO153121C
(en)
1986-01-22
FR2390159A1
(en)
1978-12-08
SE8201350L
(en)
1982-03-04
NO840064L
(en)
1978-11-13
IT7823207D0
(en)
1978-05-10
JPS53142514A
(en)
1978-12-12
IL61475A0
(en)
1980-12-31
NO153121B
(en)
1985-10-14
NO150184C
(en)
1984-09-05
CA1114758A
(en)
1981-12-22
FR2390159B1
(en)
1983-01-14
US4311712A
(en)
1982-01-19
DE2818655C2
(en)
1987-05-14
JPS6252724B2
(en)
1987-11-06
CH652615A5
(en)
1985-11-29
DE2818655A1
(en)
1978-11-23
NL7805005A
(en)
1978-11-14
NO150184B
(en)
1984-05-28
CH650944A5
(en)
1985-08-30
NZ186696A
(en)
1980-10-08
Similar Documents
Publication
Publication Date
Title
AU514644B2
(en)
1981-02-19
Liposomes
AU520916B2
(en)
1982-03-04
Preparing liposomes
AU3409978A
(en)
1979-09-20
4-acylaminophenyl-ethanolamines
AU3506678A
(en)
1979-10-18
Polyetheramide-acids
AU3782678A
(en)
1980-01-10
1-acyl-2-cyanoaziridines
AU3662478A
(en)
1979-12-06
Pyridobenzodiazepines
AU3069177A
(en)
1979-06-21
Inkduct
AU3780378A
(en)
1980-01-10
Circuit-tester
AU3347978A
(en)
1979-08-30
Phenyl-benzimidazoyl-furanes
AU3770478A
(en)
1980-01-10
3-indolyl-tertiary butylaminopropanole
AU3662278A
(en)
1979-12-06
Pyridobenzoiazepines
AU3216478A
(en)
1979-07-12
Phenylcarbamoyl-2-pyrazolines
AU3216278A
(en)
1979-07-12
Phenylcarbamoyl-pyrazolines
AU3732478A
(en)
1980-01-03
a-ETHYNYL TRYTOPHANES
AU3239278A
(en)
1979-07-19
Dithienylalkylamines
AU3307178A
(en)
1979-08-16
Chloroacetanylides
AU3764478A
(en)
1980-01-03
Benzylpyrimidines
AU3401278A
(en)
1979-09-13
Sipper-seal
AU3492478A
(en)
1979-10-18
4-alkylthio-2-trifluoromethylalkanesulfonides
AU3732678A
(en)
1980-01-03
Alpha-vinyl tryptophanes
AU3706678A
(en)
1979-12-20
Pyridazinylhydrazines
AU3418778A
(en)
1979-09-20
Hydroxylated-1d-2d-methylene-steroids
AU3246878A
(en)
1979-07-26
Arylenedioxy-bis-diketones
AU3670578A
(en)
1979-12-06
4-phenyl-8-amino-tetrahydroisoquinolines
AU3615578A
(en)
1979-11-22
17-beta-hydroxy-delta 4-androsten-3-ones
None